RE:RE:RE:RE:RE:What happens if Oast does not agree?lscfa wrote: Why the hell would AEZS shareholders agree to redirect all its cash to CZO initiatives and abandon development of its own projects?
They are creating a long-term sustainable business. Together they will have AEZS's test royalties plus CZO's base business revenue. AEZS capital(cash, upfront diagnostic, milestones) could be put into CZO's near-term revenue generating opportunities providing growing revenue generation near-term to support the company. They will also have a diversified basket fo drugs(AEZS's, and CZO's). Gilles calls AEZS's projects "exciting": "
exciting projects Aeterna". These drugs now appear before 'go'/'no go' clinical trial decisions. Together they could have the infrastructure to better support clinical trials as a drug company.